New program aims to close cancer screening gaps for rural families
NCT ID NCT07381985
First seen Feb 02, 2026 · Last updated Jun 20, 2026 · Updated 23 times
Summary
This study tests a two-year follow-up program for 200 adults with hereditary cancer syndromes like BRCA or Lynch syndrome. Participants get personalized care plans and regular check-ins with a genetics doctor to help them follow cancer prevention and screening guidelines. The goal is to see if this support improves how well people stick to recommended care, especially those living in rural areas.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYNCH SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Vermont Medical Center
Burlington, Vermont, 05401, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Longitudinal Cancer Genetics Follow-Up Program (behavioral intervention)
What this could lead to
If successful, this program could help more people with hereditary cancer risks get the right screenings and preventive care, potentially catching cancers earlier or preventing them.
What could go wrong
This is a small, early-stage study with only 200 participants, and it focuses on adherence rather than directly preventing cancer. Results may not apply to all populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.